Venous Diseases
From the Journals
DIVA results similar for drug-eluting, bare-metal stents
In the DIVA trial, outcomes were similar for patients with failed saphenous vein graft lesions who received either drug-eluting or bare-metal...
Conference Coverage
Predicting stent failure in the treatment of May-Thurner syndrome
BOSTON – "This data is hopefully the first step in allowing us to guide intra-operative decision making."
Video
ASCEND: Aspirin, fish oil flop in diabetes
MUNICH – No benefit for primary cardiovascular prevention seen in massive ASCEND trial.
News from the FDA/CDC
FDA approves Doptelet for liver disease patients undergoing procedures
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure....
From the Journals
Adding vasopressin in distributive shock may cut AF risk
Adding vasopressin cut risk of atrial fibrillation, compared with catecholamine vasopressors alone.
Feature
New BP guidelines synergize with transformed primary care
The new ACC/AHA BP guidelines fit the system approach to primary care that has transformed U.S. medicine over the past decade.
Conference Coverage
Heart disease in GPA exacts high toll in year 2 and beyond
LIVERPOOL, ENGLAND - Heart disease accounts for most granulomatosis with polyangiitis deaths 1-5 years after diagnosis.
Conference Coverage
Drug-coated balloons: The future of hemodialysis access?
Patency rates with drug-coated balloons are superior to standard balloon angioplasty for stenotic AV fistulae and grafts.
From the Journals
Early endovenous ablation speeds venous ulcer healing
Treating venous ulcers early with endovenous ablation could significantly improve healing times and delay the recurrence of ulcers.
Conference Coverage
Controversy surrounds calf vein thrombosis treatment
CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.